How much does a box of tucatinib/tucatinib cost?

Tucatinib/Tucatinib (Tucatinib) is a targeted drug focused on the treatment of HER2-positive breast cancer. It is also suitable for some patients with brain metastases. Its mechanism of action is to selectively inhibit the activity of HER2 tyrosine kinase, thereby blocking the signal transduction pathway of tumor cells. Unlike early HER2 inhibitors, tucatinib has high selectivity for HER2 but weak inhibition of EGFR. Therefore, while exerting anti-tumor effects, it can reduce adverse reactions such as rash and diarrhea and improve patients' tolerance and quality of life. Clinically, doctors often use tucatinib in combination with trastuzumab and capecitabine to treat patients with HER2-positive locally advanced or metastatic breast cancer, especially those who still have disease progression after previously receiving trastuzumab and other HER2-targeted regimens.

In terms of price, the original drug Tucatinib (trade name: TUKYSA) in the European market is priced at approximately RMB 40,000 per box of 150 mg 84 tablets, but the specific price will be affected by exchange rate changes and regional tax rates. Some European countries or medical insurance systems will implement a reimbursement mechanism for this drug, thereby reducing the patient's out-of-pocket payment ratio. In comparison, some overseas markets such as Laos, Bangladesh and other places have already launched generic drugs. The product price of 150 mg 60 tablets is about more than 2,000 yuan, and the ingredients are consistent with the original drug. The launch of generic drugs allows more patients to obtain targeted treatments at lower costs, which is undoubtedly a great benefit for patients with limited financial conditions.

However, the choice of original drug or generic drug should be considered based on the doctor's advice and personal condition. For patients receiving targeted therapy, drug stability and efficacy consistency are particularly critical. With the tightening of global drug quality supervision, some high-quality generic drugs have reached the original research standards, but it is still recommended to purchase drugs through formal channels to avoid risks caused by unknown drug sources.

Reference materials:https://www.tukysa.com/